| Product NDC: | 54868-6287 |
| Proprietary Name: | Brimonidine Tartrate |
| Non Proprietary Name: | Brimonidine Tartrate |
| Active Ingredient(s): | 2 mg/mL & nbsp; Brimonidine Tartrate |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54868-6287 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076260 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110725 |
| Package NDC: | 54868-6287-0 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (54868-6287-0) > 5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 54868-6287-0 |
| Proprietary Name | Brimonidine Tartrate |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (54868-6287-0) > 5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 54868-6287 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Brimonidine Tartrate |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20110725 |
| Marketing Category Name | ANDA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | BRIMONIDINE TARTRATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |